CK
Ceryvyn Therapeutics Limited
CKDXF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $13.7M
P/E Ratio 0.06x
Div. Yield -
ROE -
Bulios Fair Price
$0.02
100.0% upside
Trenutna cena
$0.01
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CKDXF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
75 /100
Cheap P/B 0.67x
P/E 0.06x
P/S 19,797.10x
Growth
0 /100
Declining Rev. growth 81.44%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1,196,070.00%
Gross margin 0.00%
FCF margin 1,251,230.00%
Quality
21 /100
Poor Asset turnover 0.00x
ROIC 40.37%
ROA 1,034.84%
Debt
69 /100
Low Int. coverage -1.08x
Debt/Equity 0.00x
Current ratio 13.78x
Stability
11 /100
Unstable EPS volatility 110.56%
Beta 1.51x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CKDXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeremy Max Levin Ba Zoology Dphil Mb Bchir
Employees
33
Headquarters
Melbourne
Prihajajoči dogodki
23 FEB.
Earnings
Upcoming earnings report